Ryuji Hamamoto

Molecular Biology · 2002–2020

A researcher in the Science corpus: 65 papers; trusts 119 researchers and is trusted by 35 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 473 citations into it; #753 of 17,773 by trust here, #683 by citations
• Oncology — 137 citations into it
• Artificial Intelligence — 114 citations into it
• Computer Vision and Pattern Recognition — 85 citations into it
• Representation & Self-Supervised Learning — 21 citations into it
• Plant Science — 19 citations into it
• Model Architectures — 13 citations into it
• Surgery — 13 citations into it; #529 of 1,106 by trust here, #287 by citations

Whom Ryuji Hamamoto trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Hyun-soo Cho
2. S. Hayami
3. G. Toyokawa
4. Geoffrey E. Hinton
5. Masanori Yoshimatsu
6. Alex Krizhevsky
7. Claus Nebauer
8. Yoshua Bengio
9. Jason D. Buenrostro
10. Yusuke Nakamura

Who trusts Ryuji Hamamoto overall

1. Lianhua Piao
2. Takehiro Suzuki
3. Makoto Nakakido
4. Yusuke Nakamura
5. Hyun-soo Cho
6. G. Toyokawa
7. Xiaolan Deng
8. Zhenzhong Deng
9. N. Dohmae
10. S. Hayami

Papers from Ryuji Hamamoto's perspective

Ordered by how strongly the researchers Ryuji Hamamoto trusts endorse each paper. Same corpus, a different order for every researcher.

1. ImageNet classification with deep convolutional neural networks
2. Deep Residual Learning for Image Recognition (Computer Vision and Pattern Recognition)
3. Adam: A Method for Stochastic Optimization (International Conference on Learning Representations)
4. Gradient-based learning applied to document recognition
5. Long Short-Term Memory
6. Attention is All you Need (Neural Information Processing Systems)
7. Going deeper with convolutions
8. ImageNet: A large-scale hierarchical image database
9. ImageNet Large Scale Visual Recognition Challenge
10. GENERATIVE ADVERSARIAL NETS

Their papers

• SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells (2004) — 748 citations
• Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers (2011) — 455 citations
• Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers (2011) — 318 citations
• Enhanced SMYD3 expression is essential for the growth of breast cancer cells (2006) — 265 citations
• Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker (2011) — 190 citations
• Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway (2010) — 222 citations
• Abstract 3019: Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells (2011) — 207 citations
• Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer (2011) — 114 citations
• Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. (2011) — 120 citations
• A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers (2005) — 127 citations
• The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. (2007) — 149 citations
• Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells (2008) — 59 citations
• Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression. (2012) — 179 citations
• Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B (2012) — 120 citations
• Critical roles of non-histone protein lysine methylation in human tumorigenesis (2015) — 345 citations
• SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells (2015) — 50 citations
• RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation. (2012) — 196 citations
• Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. (2011) — 100 citations
• Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy (2016) — 80 citations
• Critical role of lysine 134 methylation on histone H2AX for γ-H2AX production and DNA repair (2014) — 106 citations